Afyx Development A/S: Financial statements 2015
CVR: 35839739
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Afyx Development A/S (CVR 35839739) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -1,790,528 and a net result of DKK -1,469,551. Equity in the 2015 report amounted to DKK 11,614,147. The solvency ratio was 92%.
- Gross Profit
- DKK -1,790,528
- Profit/Loss
- DKK -1,469,551
- Equity
- DKK 11,614,147
- Total Assets
- DKK 12,630,624
Official annual report
How creditworthy is Afyx Development A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 30, 2015, Mads Spangaard Rasmussen has joined the board of directors of Afyx Development A/S.
As of September 30, 2015, René Jørgen Spogard has joined the board of directors of Afyx Development A/S.
As of September 30, 2015, Jens Hansen has left the board of directors of Afyx Development A/S.
Afyx Development A/S has published its interim report for the period April 30, 2014 – December 31, 2014.
As of May 28, 2015, Lars Hellerung Christiansen has joined the board of directors of Afyx Development A/S.
As of March 5, 2015, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Afyx Development A/S.
As of March 5, 2015, Keld Aage Søndergaard has joined the board of directors of Afyx Development A/S.
As of March 5, 2015, Jens Hansen has joined the board of directors of Afyx Development A/S.
As of March 5, 2015, Hans Anders Åkerlund has joined the board of directors of Afyx Development A/S.
About Afyx Development A/S
Afyx Development A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Juan Møller-San Pedro. The board consists of Ole Baadsgaard (chair), Claus Juan Møller-San Pedro, Pia Leah Møller-San Pedro and Søren Mohrsen Kjær. The company is owned by Afyx Therapeutics A/S. The company has 8 employees (2018). In 2025, the company reported a gross profit of DKK -5,044,782 and a net result of DKK -4,260,251 compared with DKK -6,896,490 the year before. Equity in the 2025 report amounted to DKK -7,253,987.